CD274 and adenocarcinoma: A recently published meta-analysis by Tuminello et al. included more than 10,000 surgical patients (stages I-III NSCLC), and high PD-L1 expression was associated with poor survival, statistically significant in adenocarcinoma, but not in squamous cell carcinoma [32].